title: Ocular chrysiasis.
abstract: Elemental gold, administered parenterally and orally, is used to a moderate extent to treat rheumatoid arthritis, Sjögren's syndrome and nondisseminated lupus erythematosus. Deposition of gold salts are observable in ocular tissues during chrysotherapy. These tissues are the cornea, conjunctiva, skin, lens and retina. This case report describes ocular chrysiasis and discusses its clinical management.
authors.affiliation: New England College of Optometry, Boston, MA 02115.
authors.forename: D W
authors.initials: DW
authors.lastname: Tierney
mesh_terms: D000284:Administration, Oral; D001310:Auranofin / Q000627:therapeutic use; D003316:Corneal Diseases / Q000139:chemically induced; D005123:Eye / Q000378:metabolism; D005128:Eye Diseases / Q000139:chemically induced* / Q000378:metabolism; D005260:Female; D006046:Gold / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism; D007263:Infusions, Parenteral; D008875:Middle Aged
chemical_list: D001310:Auranofin; D006046:Gold